SELZENTRY is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Maraviroc.
Product ID | 49702-237_3d3637cd-c64c-497d-80f0-7c010dea09ac |
NDC | 49702-237 |
Product Type | Human Prescription Drug |
Proprietary Name | SELZENTRY |
Generic Name | Maraviroc |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 2016-11-04 |
Marketing Category | NDA / NDA |
Application Number | NDA208984 |
Labeler Name | ViiV Healthcare Company |
Substance Name | MARAVIROC |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2016-11-04 |
Marketing End Date | 2024-10-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208984 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-11-04 |
Ingredient | Strength |
---|---|
MARAVIROC | 20 mg/mL |
SPL SET ID: | 46f30ac5-c96b-429e-976d-8c5ee1c0761b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
49702-223 | SELZENTRY | maraviroc |
49702-224 | SELZENTRY | maraviroc |
49702-233 | SELZENTRY | maraviroc |
49702-235 | SELZENTRY | maraviroc |
49702-237 | SELZENTRY | maraviroc |
49702-260 | SELZENTRY | maraviroc |
50090-1486 | SELZENTRY | maraviroc |
50090-6238 | SELZENTRY | maraviroc |
31722-579 | Maraviroc | Maraviroc |
31722-580 | Maraviroc | Maraviroc |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SELZENTRY 77183318 3372315 Live/Registered |
PHIVCO-1 LLC 2007-05-17 |